On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Hepatocellular Carcinoma Treatment and Prognosis

TopicLeading institutions, researchers & key papers

Hepatocellular Carcinoma Treatment and Prognosis is a topic indexed in ScholarIQ from OpenAlex.

What is known about Hepatocellular Carcinoma Treatment and Prognosis?

ScholarIQrecord summary

This cluster of papers focuses on the management, diagnosis, and treatment of hepatocellular carcinoma (HCC), also known as liver cancer. It covers various aspects including clinical practice guidelines, radiofrequency ablation, use of sorafenib, liver resection, and survival rates.

How many works does Hepatocellular Carcinoma Treatment and Prognosis have?

ScholarIQindexed works

Hepatocellular Carcinoma Treatment and Prognosis has 130,238 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Hepatocellular Carcinoma Treatment and Prognosis have?

ScholarIQcitation count

Hepatocellular Carcinoma Treatment and Prognosis has 2,394,724 citations in the OpenAlex counts ScholarIQ stores.

What is the OpenAlex record for Hepatocellular Carcinoma Treatment and Prognosis?

ScholarIQopenalex

The OpenAlex for Hepatocellular Carcinoma Treatment and Prognosis is on the source record.

Who are the most-cited researchers behind Hepatocellular Carcinoma Treatment and Prognosis?

ScholarIQtop researchers by citations
1
Douglas G. Altman · Meta-analysis and systematic reviews
954 works850,975 citations
2
Christopher J L Murray · Global Maternal and Child Health
1,001 works574,586 citations
3
Freddie Bray · Global Cancer Incidence and Screening
657 works545,730 citations
4
Jacques Ferlay · Global Cancer Incidence and Screening
212 works482,584 citations
5
Simon I Hay · Malaria Research and Control
909 works442,743 citations

Where is Hepatocellular Carcinoma Treatment and Prognosis research published, and who funds it?

ScholarIQvenues & funding sources

TOP JOURNALS

No journal data available yet.

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

Who collaborates most closely around Hepatocellular Carcinoma Treatment and Prognosis?

ScholarIQco-authorship network

Related on ScholarIQ

470M+ articles · free account